Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03024866 · ClinicalTrials.gov registry record
Comparison of eBX and Mohs Surgery for Treatment of Early-stage Non-melanoma Skin Cancer a Matched Pair Cohort Study.
A clinical trial of Non-Melanoma Skin Cancer, sponsored by Xoft.
- Completed
- Registry status
- 369
- Enrollment target
- 4
- Study locations
NCT03024866: Completed study of Non-Melanoma Skin Cancer, sponsored by Xoft.
NCT03024866 is a study of Non-Melanoma Skin Cancer that has completed, run by Xoft. The registered enrollment target is 369 participants, above the 55-participant average among 7 other Non-Melanoma Skin Cancer trials with a reported enrollment target (571% higher). The trial reports 4 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03024866, a study of Non-Melanoma Skin Cancer, has completed, sponsored by Xoft.
- COMPLETED
- Registry status
- 369 participants
- Enrollment target
- 4
- Study locations
Study Summary
This is a retrospective-prospective study design. Patients who completed treatment approximately 3 years (range of 2-4 years) at time of IRB approval of this study will be identified and any existing data in the patient's record will be collected in addition to conducting office visits for long-term follow-up.
Primary Outcome
Subjects treated with Xoft eBx or MMS over 3 years prior were called in for a long-term prospective visit, consented, and assessed for skin cancer recurrence at the previously treated site.
Conditions Studied
Interventions
- PROCEDURE Electronic Brachytherapy
Study Locations (4)
California
- Kenneth A. Miller, PC - Los Gatos
- Dermatology & Laser Center of San Diego - San Diego
- Dermatology and Laser Center of San Diego - San Diego
Nevada
- Strimling Laser and Vein Institute - Las Vegas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 369 participants |
| Start Date | 2016-10 |
| Est. Completion | 2017-03 |
What the finished NCT03024866 record still lists
NCT03024866 is an observational study that tracks outcomes without assigning an intervention. The registered 369 participants enrollment target is mid-sized for trials with a published cap, above the 55-participant average among 7 other Non-Melanoma Skin Cancer trials with a reported enrollment target (571% higher).
The record links to 1 condition, with Non-Melanoma Skin Cancer appearing as the primary indexed condition, and to 1 intervention - of which Electronic Brachytherapy is the first listed.
NCT03024866 reports a single indexed study location in California, Nevada.
Frequently Asked Questions
What is clinical trial NCT03024866 about?
NCT03024866 is a clinical study titled "Comparison of eBX and Mohs Surgery for Treatment of Early-stage Non-melanoma Skin Cancer a Matched Pair Cohort Study.". This is a retrospective-prospective study design. Patients who completed treatment approximately 3 years (range of 2-4 years) at time of IRB approval of this study will be identified and any existing data in the patient's record will be collected in addition to conducting office visits for long-term...
What is the current status of trial NCT03024866?
This trial is currently completed. The enrollment target is 369 participants. The study started on 2016-10. Estimated completion is 2017-03.
What conditions does trial NCT03024866 study?
This clinical trial studies the following conditions: Non-Melanoma Skin Cancer.
What interventions are being tested in trial NCT03024866?
The interventions under investigation include: Electronic Brachytherapy (PROCEDURE).
Who is sponsoring clinical trial NCT03024866?
This trial is sponsored by Xoft, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03024866 being conducted?
This trial has 4 study locations across California, Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Non-Melanoma Skin Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia
RECRUITING · NA
-
The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population
RECRUITING · NA
-
Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck
RECRUITING · NA
-
Experience of Non-Melanoma Skin Cancer (NMSC) Mohs Surgery Project
COMPLETED
-
Preoperative Acetaminophen and Carbohydrate Loading
COMPLETED · Phase 3
-
Dietary Prevention of Photodamage in Skin With Grapes
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06114836 · 369 participants · NA
GERD Infant Feeding Therapeutics Trial (GIFT Trial)
- NCT06585410 · 369 participants · Phase 3
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
- NCT07256717 · 369 participants · NA
BPIT 5-Week Multi-Site Study: Movement Efficiency, Mobility & Neuromuscular Adaptation
- NCT02332668 · 370 participants · Phase 1
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia